Company: TELO
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010298
Chunk: 50

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 2
Chunk 50
---
None.

Item
3. Defaults upon Senior Securities.

None.

Item
4. Mine Safety Disclosures.

Not
applicable.

Item
5. Other Information.

Not
applicable.

Item
6. Exhibits.

    Number
     
    Description

    31.1*
     
    Certification
    of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
    2002*
  
    31.2*
     
    Certification
    of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
    2002*
  
    32.1*
     
    Certification
    of Principal Executive Officer and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the
    Sarbanes-Oxley Act of 2002.
  
    101.INS*
     
    Inline
    XBRL Instance Document
  
    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema
  
    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase
  
    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase
  
    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Label Linkbase
  
    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase
  
    104*
     
    Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    *
    Furnished
    herewith

    ^
    Previously
    filed.

    +
    Denotes
    management contract or compensatory plan or arrangement.

20

SIGNATURES

Pursuant
to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    TELOMIR
    PHARMACEUTICALS, INC.

    Date:
    May 14, 2025
    By:
    /s/
    Erez Aminov

    Erez
    Aminov

    Chief
    Executive Officer & Chairman

    (Principal
    Executive Officer)